Brief: Statistical Significance Confirmed In Final Analysis Of Chordate’s PM007 Multicenter Clinical Study
Nov 3 (Reuters) - Chordate Medical Holding publ AB
CMHM.ST :
* STATISTICAL SIGNIFICANCE CONFIRMED IN FINAL ANALYSIS OF
CHORDATE’S PM007 MULTICENTER CLINICAL STUDY OF THE K.O.S
TECHNOLOGY FOR PREVENTIVE TREATMENT OF CHRONIC MIGRAINE
Source text for Eikon: ID:nMFNc6R4Kc
Further company coverage: CMHM.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Chordate Medical Holding AB (publ)
See all newsBrief: Chordate Applies For Delisting
Brief: Chordate Medical Holding Says Last Day Of Trading Is In March 2026
Brief: Chordate Medical To Enter Into Voluntary Liquidation
Brief: Chordate Board Proposes AGM To Resolve On Voluntary Liquidation And Delisting
Brief: Chordate Medical Holding Q2 Net Loss SEK 5.2 Mln